Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
63.66
-0.33 (-0.52%)
At close: Dec 5, 2025
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 39.26 billion as of December 5, 2025. Its market cap has increased by 155.36% in one year.
Market Cap
39.26B
Enterprise Value
37.50B
Revenue
1.37B
Ranking
n/a
PE Ratio
45.75
Stock Price
63.66
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 39.26B, an increase of 17.78%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 39.26B | 197.20% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | 15.19B | -54.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 404.98B |
| WuXi AppTec | 260.08B |
| Shenzhen Mindray Bio-Medical Electronics | 241.27B |
| Sichuan Biokin Pharmaceutical | 149.34B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 105.51B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.40B |